ZEN Stock Overview
Engages in the research and development of graphene and related nanomaterials in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Zentek Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.37 |
| 52 Week High | CA$2.23 |
| 52 Week Low | CA$1.30 |
| Beta | 0.91 |
| 11 Month Change | -8.67% |
| 3 Month Change | -10.46% |
| 1 Year Change | -35.07% |
| 33 Year Change | -57.59% |
| 5 Year Change | 356.67% |
| Change since IPO | 124.59% |
Recent News & Updates
Recent updates
Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?
Jul 09
Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?
Aug 31We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate
Mar 11We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully
Nov 26Shareholder Returns
| ZEN | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | -1.4% | -1.1% | 0.7% |
| 1Y | -35.1% | -33.1% | 10.7% |
Return vs Industry: ZEN underperformed the Canadian Medical Equipment industry which returned -31.6% over the past year.
Return vs Market: ZEN underperformed the Canadian Market which returned 11.8% over the past year.
Price Volatility
| ZEN volatility | |
|---|---|
| ZEN Average Weekly Movement | 7.8% |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in CA Market | 16.7% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ZEN has not had significant price volatility in the past 3 months.
Volatility Over Time: ZEN's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 24 | Greg Fenton | www.zentek.com |
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis.
Zentek Ltd. Fundamentals Summary
| ZEN fundamental statistics | |
|---|---|
| Market cap | CA$138.69m |
| Earnings (TTM) | -CA$11.70m |
| Revenue (TTM) | CA$29.82k |
4,651x
P/S Ratio-11.8x
P/E RatioIs ZEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZEN income statement (TTM) | |
|---|---|
| Revenue | CA$29.82k |
| Cost of Revenue | CA$414.88k |
| Gross Profit | -CA$385.06k |
| Other Expenses | CA$11.32m |
| Earnings | -CA$11.70m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | -1,291.45% |
| Net Profit Margin | -39,254.06% |
| Debt/Equity Ratio | 3.8% |
How did ZEN perform over the long term?
See historical performance and comparison